come an essential tool for gastrointestinal endoscopy. The development of the linear EUS scope enabled not only direct visualization of the lesions along the path of the scope but also EUSguided tissue acquisition (EUS-TA). Nowadays, EUS-TA serves as one of the best diagnostic choices in many diseases involving the gastrointestinal tract and its adjacent structures. EUS-TA is well known for its high accuracy and safety. However, several factors can affect outcomes of EUS-TA. The endosonographer's experience, the size and location of the lesion, the size and type of the needle, the specific techniques of the procedure, the presence of a cytopathologist for rapid on-site examination, and the cytologist's expertise are some of the important factors that can influence procedure outcomes. 2, 3 In EUS-TA, needles are used for EUS-guided fine-needle aspiration (FNA) and EUS-guided fine-needle biopsy (FNB). Cytological samples obtained by EUS-FNA provide relatively high diagnostic accuracy, but cytological evaluation alone without histology sometimes has limitations in confirming diagnoses. A meta-analysis of the diagnostic performance of EUS-FNA for a solid pancreatic mass showed pooled sensitivity of 87% and pooled specificity of 96%. 4 FNB needles are better to obtain tissue cores than FNA needles. 5 Tissue cores with preserved architecture and immunohistochemical stain are beneficial for the diagnosis of a few specific diseases, such as mesenchymal tumors, well differentiated adenocarcinomas, lymphomas, cancers in chronic pancreatitis, and autoimmune pancreatitis. In addition, with the rise of personalized medicine, it is now necessary to obtain more tissue for next-generation sequencing, molecular analysis, and organoid generation. Initially, the 19-gauge Tru-Cut biopsy needle was developed to harvest core tissues. However, this needle presented a host of issues, such as elevated procedure costs and complication rates, difficulty in manipulation, and difficulty in using the transduodenal approach. Many studies have compared the relationship between needle size and effectiveness. When findings from the literature are compiled, conclusions remain contradictory; some findings indicate that significant differences exist, while others show no differences with respect to needle size and effectiveness. Largebore needles have been shown to produce significantly higher cellular yields but are less successful in approaching the pancreatic head due to its rigidity. The 25-gauge ProCore ® needle was better than other needles at targeting the pancreatic head and uncinate lesions through the transduodenal route. 9 Which needle is the most ideal for EUS-TA? Various needles have their own advantages and disadvantages in certain aspects, such as visibility, ease of puncture, technical success rate, specimen quality, cost effectiveness, and complication rates. Although FNB needles are more expensive, produce bloodier samples, and induce greater tissue trauma, they provide a large amount of sample, facilitating ancillary testing. In the absence of rapid on-site examination by a cytopathologist, the FNB needle is associated with better diagnostic adequacy in solid pancreatic lesions. In comparision, FNA needles are cheaper, less invasive, and have much lower complication rates than FNB needles.
To choose the correct needle, the endosonographer should first consider the characteristics of the lesion, including location and size. Then, he or she should evaluate the probable diagnosis, since the core biopsy would be essential for diagnosis in certain cases. 10 If core tissue is needed, the use of an FNB needle or a 19-gauge FNA needle should be considered. If the access route is transduodenal, a 25-gauge needle would be the ideal choice. Otherwise, either 22 or 25-gauge needles would be acceptable.
